Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-29

FDA Approved: CRYSELLE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CRYSELLE (norgestrel and ethinyl estradiol) from Teva Pharmaceuticals, updating the labeling via a supplemental subm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CRYSELLE (NORGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for CRYSELLE (NORGESTREL AND ETHINYL ESTRADIOL)